Monte Rosa Therapeutics, Inc. (GLUE)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 297.41M |
| Enterprise Value | 111.04M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 1.66 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -0.81 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 1.45 |
| 52-Week Change 3 | 19.52% |
| S&P500 52-Week Change 3 | 23.57% |
| 52 Week High 3 | 8.84 |
| 52 Week Low 3 | 2.44 |
| 50-Day Moving Average 3 | 6.44 |
| 200-Day Moving Average 3 | 5.46 |
Share Statistics
| Avg Vol (3 month) 3 | 137.06k |
| Avg Vol (10 day) 3 | 113.65k |
| Shares Outstanding 5 | 50.15M |
| Implied Shares Outstanding 6 | 50.15M |
| Float 8 | 23.74M |
| % Held by Insiders 1 | 0.86% |
| % Held by Institutions 1 | 98.16% |
| Shares Short (Apr 15, 2024) 4 | 1.87M |
| Short Ratio (Apr 15, 2024) 4 | 11.37 |
| Short % of Float (Apr 15, 2024) 4 | 6.93% |
| Short % of Shares Outstanding (Apr 15, 2024) 4 | 3.72% |
| Shares Short (prior month Mar 15, 2024) 4 | 1.83M |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | N/A |
| Last Split Date 3 | N/A |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Dec 31, 2023 |
Profitability
| Profit Margin | 0.00% |
| Operating Margin (ttm) | 0.00% |
Management Effectiveness
| Return on Assets (ttm) | -27.72% |
| Return on Equity (ttm) | -60.07% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -137.09M |
| Net Income Avi to Common (ttm) | -135.35M |
| Diluted EPS (ttm) | -2.63 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 232.41M |
| Total Cash Per Share (mrq) | 4.64 |
| Total Debt (mrq) | 46.04M |
| Total Debt/Equity (mrq) | 25.68% |
| Current Ratio (mrq) | 5.07 |
| Book Value Per Share (mrq) | 3.58 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -43.8M |
| Levered Free Cash Flow (ttm) | -55.47M |
© 2024 Yahoo. All rights reserved.